BioSpace News Archive

Charles River Laboratories International, Inc. (NYSE: CRL) and Valo Health, Inc (“Valo”) have launched Logica TM , an artificial intelligence (AI) powered drug solution that directly translates clients’ biological insights into optimized preclinical assets.

Highland Therapeutics Inc. today announced the appointment of Stephanie C. Read as President/Chief Executive Officer, the appointment of Scott Myers as Chair of the Board and the additions of Kevin Bain and Ildiko Mehes as independent members of the Board of Directors.

Sonendo , Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, is participating in the American Association of Endodontists’ (AAE) Annual Meeting taking place from April 27-30, 2022 in Phoenix, AZ.

Paragon 28, Inc. announced today an expansion of its hammertoe and soft-tissue portfolio with the launch of its Paratrooper™ Plantar Plate Repair System.

Visus Therapeutics Inc. today announced that it will present new scientific data at the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting , to be held May 1-4, 2022 in Denver, Colorado.

Truvian Sciences President and CEO Jeff Hawkins joins leaders of the nation’s most innovative labs to share new technologies and approaches to improve patient outcomes.

Vir Biotechnology, Inc. announced that the Company will review its robust hepatitis portfolio, including initial data from the first cohort of the MARCH trial evaluating VIR-2218 in combination with VIR-3434, as well as a new program aimed at chronic hepatitis D. Details will be discussed at 12:00 pm ET / 9:00 am PT during Vir’s virtual Hepatitis Portfolio R&D Day.

Guardian Research Network, Inc. (GRN) and Cytel Inc. are pleased to announce an upcoming presentation at ISPOR 2022, Washington, DC. ISPOR is the leading professional society for health economics and outcomes research.

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced that Arpa Garay will join Moderna as Chief Commercial Officer, effective Monday, May 31, 2022.

LifeScan, a world leader in blood glucose monitoring, announced today the presentation of three studies showing the value of app-based technology in improving diabetes management.